AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT00409071 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cocculine®
Description: 12 tablets in 3 days at each of the CT courses: 2 on the day before evening of the CT courses; 2 on the morning, noon and evening of the CT courses; 2 on morning and noon of the day after the CT courses.
Study NCT00409071 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: placebo
Description: 12 tablets in 3 days at each of the CT courses: 2 on the day before evening of the CT courses; 2 on the morning, noon and evening of the CT courses; 2 on morning and noon of the day after the CT courses.
Study NCT02119871 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Bilateral Open Pleurae
Description: Both pleurae are opened Right pulmonary vein drainage
Study NCT02119871 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Right Pleura Open
Description: Right pleura open Left ventricular apical drainage
Study NCT00664547 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Diet Weight Loss
Study NCT00664547 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Exercise Weight Loss
Study NCT00664547 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Exercise Without Weight Loss
Study NCT02763423 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: umbilical cord mesenchymal stem cell
Description: allogeneic umbilical cord mesenchymal stem cell transplantation by intravenous injection
Study NCT03028298 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Low dose sildenafil citrate
Study NCT03028298 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: High dose sildenafil citrate
Study NCT00866424 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Hyperbaric oxygen, Mock hyperbaric chamber
Description: Hyperbaric oxygen treatment for 10 days in treatment groups and mock hyperbaric chamber treatment for 10 days in control groups.~Hyperbaric oxygen treatment: While in the hyperbaric chamber the subjects breathe 100% oxygen saturation with mask at 2.0bars.~Mock hyperbaric chamber treatment: The subjects breathe air freely in the imitation environment chamber at 1.0bars.
Study NCT01186666 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Coronary intervention using IVUS-VH & FDG PET-MDCT
Description: All the patients will undergo percutaneous coronary intervention of culprit vessels after imaging of the entire coronary tree (culprit and non-culprit lesions) using intravascular ultrasound with radiofrequency data analysis (IVUS-VH). Before discharge, fluorodeoxyglucose positron emission tomography combined with multidetector computed tomography (FDG PET-MDCT) of the carotid arteries and the thoracic aorta, along with MDCT coronary angiography, will be performed and a blood sample will be obtained for subsequent measurements of emerging or new biomarkers.
Study NCT03780049 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: HAIC of FOLFOX
Description: administration of Oxaliplatin , fluorouracil, and leucovorin via the tumor feeding arteries
Study NCT03780049 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: HAIC of FOLFOX
Description: administration of Oxaliplatin , fluorouracil, and leucovorin via the tumor feeding arteries
Study NCT03780049 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: H101
Description: Patients receive H101 0.5ml dissolved in 10ml normal saline in each session of HAIC
Study NCT03780049 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Placebos
Description: Patients receive normal saline 10ml in each session of HAIC
Study NCT02266316 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Air warming mask
Description: Mask that warms air at the mouth
Study NCT06301230 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Portable Laparoscopic Trainer (PLET)
Description: The PLET trainer is light and easy to transport packed in a bag and consists of a foldable plastic box, which can be assembled in less than 30 seconds by means of simple handles. There are three accesses for the surgical instruments (ports) as well as a central recess over which a tablet with an integrated camera can be placed.~Each participant received a previously prepared opaque envelope containing a black or white USB stick from the Principal Investigator with the assignments on it as part of the randomization process. The outcome assessors were blinded to the allocation.
Study NCT06301230 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Portable Laparoscopic Trainer (PLET)
Description: The PLET trainer is light and easy to transport packed in a bag and consists of a foldable plastic box, which can be assembled in less than 30 seconds by means of simple handles. There are three accesses for the surgical instruments (ports) as well as a central recess over which a tablet with an integrated camera can be placed.~Each participant received a previously prepared opaque envelope containing a black or white USB stick from the Principal Investigator with the assignments on it as part of the randomization process. The outcome assessors were blinded to the allocation.
Study NCT01998230 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: early oral feeding
Description: In the early oral feeding group, the patients are encouraged to intake liquid food on post operative day 1.
Study NCT04564664 — intervention group
Intervention type: DRUG
Group type: OTHER
Intervention: Oxygen
Description: High-flow nasal cannula oxygen therapy vs. standard oxygen therapy
Study NCT02575534 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Procainamide
Description: the procainamide will be infused at 12mcg/kg up to a max of 1 gram at a rate of 20mg/min which will take up to 1 hour to infuse
Study NCT04400630 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Physical exercise
Description: The experimental group will receive supervised physical exercise treatment by high-intensity interval training (HIT), alternating high and moderate intensities (20 min). The participants will exercise two non-consecutive days per week for 16 weeks under supervision by exercise specialists.
Study NCT03358277 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: MPH + APZ
Description: MPH was administered with either Ritalin (from 10mg/day to 40mg/day) or Concerta (from 18mg/day to 36mg/day) according to clinical judgement for six weeks. APZ was administered with dose from 2.5mg/day to 5mg/day according to clinical judgement for six weeks.
Study NCT01671163 — intervention group
Intervention type: PROCEDURE
Intervention: Endoscopic Ultrasound (EUS) for fiducial placement
Description: Endoscopic Ultrasound (EUS) used for the placement of fiducial markers in tissue as outlined by the radiation oncologist
Study NCT04482517 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Density Gradient Centrifugation
Description: Semen processing is done by double layer density gradient method.
Study NCT04482517 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Physiological ICSI
Description: Sperm selection by PICSI dishes depending on hyaluronan binding of sperm head
Study NCT04482517 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Magnetic activated cell sorting
Description: Sperm selection by using Annexin V micro-beads and separation columns
Study NCT04482517 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Testicular sperm
Description: Using testicular sperm retrieved by TESA or TESE
Study NCT02699658 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Levofloxacin
Study NCT02730481 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Oraxol
Description: Oraxol will be supplied as paclitaxel capsules and HM30181AK-US tablets.
Study NCT05670522 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Transcranial direct current stimulation
Description: Transcranial direct-current stimulation (tDCS), over the motor cortex, is a potential therapy option for motor control deficits in children with CP. The application of tDCS involves positioning 2 rubber electrodes sheathed in saline-soaked pads onto the scalp, held in place by a rubber strap. Low-intensity, direct-current, of 1 to 2 mA, is delivered to cortical areas from the device.~The standard-of-care gait training included various gait training and balance tasks as well as resistive exercises and passive stretching as necessary. Task-specific gait exercises included: walking in a closed indoor environment, walking in an open indoor environment, walking on various floor surfaces, and climbing stairs up and down without assistance. The children also performed dynamic balance exercises by walking on a balance board.
Study NCT05670522 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Virtual reality
Description: Virtual reality rehabilitation is an emerging therapy for motor rehabilitation of children with CP. The therapy is provided through a computer-simulated environment where they interact with real-world-like objects and events through sight, sound, and touch. The Wii Remote was used as the interactive interface, and standard computer/television screens were used as the display hardware. Therefore, VR therapy was of the non-immersive type.~The standard-of-care gait training included various gait training and balance tasks as well as resistive exercises and passive stretching as necessary. Task-specific gait exercises included: walking in a closed indoor environment, walking in an open indoor environment, walking on various floor surfaces, and climbing stairs up and down without assistance. The children also performed dynamic balance exercises by walking on a balance board.
Study NCT04113850 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Mobile Acoustic startle Reflex monitoring System (MARS)
Description: Acoustic startle testing
Study NCT03957148 — intervention group
Intervention type: BEHAVIORAL
Group type: SHAM_COMPARATOR
Intervention: Sugar-sweetened beverage reduction education for preschool children
Description: Participants in the SSB-IMB program will receive 10 weeks of SSB related nutrition education at their child's preschool. Each week a different lesson pertaining to parental information, motivation, or behavioral skills related to SSBs will be presented via an interactive display board. Twice a week, two student educators will stand by display boards for two hours and deliver the lessons that will last 5-10 minutes with each parent. These displays will include an activity for parents to apply knowledge and skills learned during the short lesson. Educators will also provide parents with informational handouts pertaining to each lesson to reinforce concepts learned. Display board education is flexible, so that if a parent arrives while another parent is receiving education, the second educator can begin the lesson with the new parent. Multiple parents can participate in a lesson at the same time. Groups of 2-3 parents can review the lesson together, learning from each other.
Study NCT03957148 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Sugar-sweetened beverage reduction education for preschool children
Description: Participants in the SSB-IMB program will receive 10 weeks of SSB related nutrition education at their child's preschool. Each week a different lesson pertaining to parental information, motivation, or behavioral skills related to SSBs will be presented via an interactive display board. Twice a week, two student educators will stand by display boards for two hours and deliver the lessons that will last 5-10 minutes with each parent. These displays will include an activity for parents to apply knowledge and skills learned during the short lesson. Educators will also provide parents with informational handouts pertaining to each lesson to reinforce concepts learned. Display board education is flexible, so that if a parent arrives while another parent is receiving education, the second educator can begin the lesson with the new parent. Multiple parents can participate in a lesson at the same time. Groups of 2-3 parents can review the lesson together, learning from each other.
Study NCT00934453 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Lactobacillus rhamnosus GG ATCC 53103
Description: Study drug capsules (1x10\^10 LGG/capsule) are to be taken orally twice a day every day dissolved in cow's milk or soy milk on an outpatient basis for six months.
Study NCT00934453 — intervention group
Intervention type: BIOLOGICAL
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo capsules composed of microcrystalline cellulose are to be taken orally twice a day dissolved in cow's milk or soy milk on an outpatient basis for six months.
Study NCT03899714 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Cryotherapy
Description: Crushed ice in a plastic bag will be used, as it is a widely accessible and financially convenient method of cryotherapy. One half of a kilogram of ice will be placed in a plastic bag. The plastic bags will be 17 cm wide and 22 cm long. The air will be squeezed out of the bag and it will be sealed. The bag will be wrapped in a wet towel and applied to the tested area. Every five bags of crushed ice will be kept in an insulated foam container containing one kilogram of dry ice. Dry ice has a temperature of negative 80 degrees Celsius, and is used to keep the bags of crushed ice in a frozen state till the participants are briefed and the testing began.
Study NCT04816448 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: cervical mobilization (Headache SNAG)
Description: For cervical mobilization the patient's position is sitting on a chair in the erect posture. The therapist handled C2 spinous process with the middle phalanx of one hand. With the other hand, he performed ventral glide asked the patient to move neck in all directions (Flexion, Extension, Side bending and rotation) one by one and then slowly move the neck back to its starting position while the therapist maintained the ventral glide.
Study NCT04816448 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Sub-occipital myofascial release
Description: For the application of the technique , the patient position is supine lying with the head fully supported on therapist's hands and therapist places 3 middle fingers just inferior to the nuchal line, lifts the fingers tips towards the ceiling while resting the head on the table and then therapist will apply a gentle upward pull. This procedure done for 2 to 3 minutes and 5 to 7 repetitions, 3 sessions per week on alternate days were given for 6 weeks.~Evaluation was done before treatment, during treatment at 4th week and after treatment at 6th week. Outcomes will be measured by NDI, PNRS and Universal Goniometer.
Study NCT02462044 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: 240 mg Iodine
Study NCT02462044 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: 300 mg Iodine
Study NCT02462044 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: 370 mg Iodine
Study NCT02710656 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Legflow® balloon
Description: Percutaneous angioplasty performed with a Drug coated balloon (DCB) with Paclitaxel
Study NCT02710656 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Standard PTA
Description: Percutaneous angioplasty performed with a standard balloon
Study NCT00683111 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: esomeprazole 20 mg daily
Description: oral famotidine 40 mg daily vs. oral esomeprazole 20 mg daily for up to 12 months
Study NCT00683111 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: famotidine 40 mg daily
Description: oral famotidine 40 mg daily vs. oral esomeprazole 20 mg daily for up to 12 months
Study NCT03072446 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Gel-Beads embolic material
Description: Patients will receive embolization of their uterine fibroids using Gel-Beads.
Study NCT02027012 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Percutaneous renal denervation with the Vessix™ Renal Denervation System
Study NCT04013308 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Iontophoresis with 2% potassium iodide
Description: 10 iontophoresis treatments with 2% potassium iodide on the area of thyroid gland; electrodes with tin foil (Amperage:2mA, duration: 30min)
Study NCT03853330 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Ultrasound
Description: Ultrasound-guided Thoracic Epidural Analgesia and Erector spinae plane block.
Study NCT03853330 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Bupivacaine HCl Inj 0.25%
Description: Bupivacaine HCl Inj 0.25% will be used in both blocks by the same dose of 7.5-12 ml
Study NCT03853330 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Bupivacaine Hydrochloride, 0.125%-0.9% Injectable Solution
Description: infusion of Bupivacaine Hydrochloride, 0.125%-0.9% Injectable Solution at 5-7 ml/h will be used in both blocks and also for breakthrough pain after both blocks as a bolus of 5-10 ml.
Study NCT03806192 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Telephone-Based Intervention
Description: Attend psychoeducational counseling sessions via telephone
Study NCT03806192 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Behavioral, Psychological or Informational Intervention
Description: Attend psychoeducational counseling sessions via video teleconference
Study NCT03806192 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Questionnaire Administration
Description: Ancillary studies
Study NCT03032562 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Multimodal measurement of respiratory muscle function and strength
Description: Sleep-studies, capnography, spiromanometry, phrenic nerve conduction studies, magnetic phrenic nerve stimulation, diaphragmatic ultrasound
Study NCT02732600 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Facilitated Implementation
Description: Facilitated Implementation sites will receive one year of support based on the i-PARIHS implementation model which includes training, implementation planning, ongoing external facilitation, feedback and consultation
Study NCT01258777 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: 400 mg golimumab or placebo
Description: Single dose of 400 mg subcutaneously
Study NCT01258777 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: 200 mg golimumab or placebo
Description: Single dose of 200 mg subcutaneously
Study NCT03289793 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Neurofeedback training
Description: Children in group A will receive BCI-based training implemented through original P300-based controlled games.~They will attend 30 1-hour long training sessions at a pace of 2 sessions per week.~Each session includes: installation of the child, the EEG system and an eye-tracking system, a 5-minutes relaxation phase, a short EEG recording at rest, a brief reminder of the instructions, 30 minutes of training by playing video games and finally a time for the child to wash her/his hair.~Moreover, 4 neuropsychological sessions will complement the 30 training sessions. During these sessions neuropsychological tests and quality of life questionnaires will be answered.
Study NCT02341131 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Cognitive Remediation Therapy
Description: The program has a duration of 40 sessions (one hour of duration), with two sessions for week during four months. It is carried out individually and utilizes paper and pencil tasks. The main technique utilized is the scaffolding (to provide strategies when the patient cannot carry out the task and to withdraw him when he is yet able of doing it alone) in a context of learning without errors.
Study NCT02341131 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Psychoeducation
Description: The program has a duration of 40 sessions (one hour of duration), with two sessions for week during four months. It is carried out individually and utilizes teaching information and coping skills and neuropsychological issues are not addressed.
Study NCT03309462 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Miseq sequencer
Description: The sequencer will be used to detect the gene mutations of the re-biopsy tissue samples and peripheral blood samples obtained from patients.
Study NCT04326166 — intervention group
Intervention type: DRUG
Intervention: Evogliptin
Description: Evogliptin
Study NCT03289793 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Active Sham control
Description: Children in group B will receive a training that is not based on brain activity, but in a blind fashion. They will attend 30 1-hour long training sessions at a pace of 2 sessions per week.~Each session includes: installation of the child, setting up the EEG and eye-tracking systems, a 5-minutes relaxation phase, short EEG recording at rest, a brief reminder of the instructions, 30 minutes of video game based training and finally a time for the child to wash her/his hair.~Besides, 4 neuropsychological sessions will complement the 30 training sessions. During these sessions neuropsychological tests and quality of life questionnaires will be performed.
Study NCT03289793 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Baseline control group
Description: The children included in this group will not receive any training. They only take part to the 4 neuropsychological sessions. Like others, they will attend 1 neuropsychological session every two months over six months.
Study NCT02826746 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Magnesium Sulfate
Description: adminstration of intravenous magnesium as bolus of 50 mg/kg, followed by continuous infusion at rate of 10 mg/kg/h
Study NCT02826746 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Normal saline
Description: the same bolus and infusion volumes of normal saline
Study NCT02919228 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Visible light exposure
Description: Subjects will be exposed to visible colored light for 15 minutes. The visible light will be generated by red-green-blue light emitting diodes light cans.